Health |Vektor Medical
Vektor Medical Completes Enrollment in IMPRoVED-AF Clinical Study and Announces Appointment of Brandon Allen as Senior Vice President of Sales
October 21, 2026 · 5:00 AM · SAN DIEGO
Vektor Medical, a medical technology company advancing the treatment of cardiac arrhythmias through its non-invasive, AI-based arrhythmia analysis technology, vMap®, today announced the completion of patient enrollment in its IMPRoVED-AF randomized clinical study and the appointment of Brandon Allen as Senior Vice President of Sales. Together, these milestones mark important progress in Vektor's efforts to expand commercial adoption of vMap and strengthen the clinica...
- PublishedOctober 21, 2026 · 5:00 AM
- LocationSAN DIEGO
- IndustryHealth
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →